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Abstract
ROLE OF C121A IN MGLUR2 HOMODIMERIC EXPRESION AND FUNCTION
By Jong Myoung Shin, Bachelors of Science
A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science
at Virginia Commonwealth University.
Virginia Commonwealth University, 2018
Director: Javier Gonzalez-Maeso, PhD
Associate Professor, Physiology and Biophysics Department
The group II metabotropic glutamate receptors are known for their involvement in
various psychiatric disorders. The mGluR2 in particular is linked with etiology of schizophrenia
especially in the context of crosstalk with 5-HT2A. Thus, the mGluR2 has attracted attentions for
its potential therapeutic applications. Despite numerous physiological evidences on the actions of
mGluR2, its mechanism is still unclear to this day. It is partially due to the lack of understanding
in characteristics of mGluR2 homodimer which is its functionally active form. Therefore, the
characterization of dimeric interaction serves as a foundation to advanced understanding of the
role of mGluR2. On that note, the role of the conserved cysteine residue (C121) in the ligand
binding domain of mGluR2 has been evaluated in this study as they are known to play a critical
part in homodimer formation. Collectively, C121 has been shown to affect the dimerization,
subcellular localization, and pharmacokinetics of mGluR2. Lastly, the effect of mGluR2 on
mouse behavior was examined in a partial effort to elucidate its role in crosstalk with 5-HT2A.
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Chapter 1. Introduction
1.1. G Protein-Coupled Receptors

G Protein-Coupled Receptors (GPCRs) comprise a large family of membrane receptors
modulated by extracellular stimulation transducing intracellular signal cascade to regulate
physiological processes in eukaryotic organism (Prazeres, 2015). There are myriad receptor
ligands including chemical compounds, hormones, neurotransmitters, small molecules, and
peptides involved in vital biological processes such as cell proliferation, migration, and
inflammation (Tadagaki, 2012). These receptors are ubiquitously expressed throughout the
system. Owing to their abundance, they are responsible for a numerous physiological
abnormalities including various psychiatric disorders (Komatsu, 2015). For such reason, the
researches to better understand functionalities of GPCRs continuously gained tractions in the
past several decades.

1.1.1. Heterotrimeric G Proteins

GPCRs are associated with guanine nucleotide-binding proteins (G-proteins) that are
either monomeric or heterotrimeric (Flock, 2015). Of those two major classes, the heterotrimeric
G-proteins are particularly important in cell signaling and receptor trafficking, hence it is an
attractive research subject from a pharmacological perspective. As the name suggests,
heterotrimeric G-proteins involve three distinctive proteins that are membrane bound: alpha (Gα),
11

beta (Gβ), and gamma (Gγ). These G-proteins act as molecular switches for pertinent GPCRs
turning the receptors on or off by binding either GTP or GDP, respectively. Depending on which
GPCRs they are associated with, the Gα proteins can be subdivided into four main subclasses
(Gαs, Gαi, Gαq, and Gα12/13) based on the protein sequence and the effectors they activate
(Beaulieu & Gainetdinov, 2011). Upon GTP hydrolysis, these G-proteins detach from the GPCR
into two separate units as Gα and Gβγ, which individually activate their corresponding effectors
such as adenylyl cyclases, phospholipases, and ion channels (Figure 1.1).

1.1.2. Class C GPCR

GRAFS classification groups GPCRs into five main families in human: Glutamate
(G/Class C), Rhodopsin (R/Class A), Adhesion (A/Class B), Frizzled (F/Class F), and Secretin
(S/Class B) (Schioth, 2005). Within these families, the class C GPCRs are known for their large
extracellular domain serving as orthosteric binding sites known as the venus flytrap domain
(Figure 1.2). Additionally, they are known to constitutively form strict dimers as a part of their
activation mechanism (Levitz, 2016; Xue, 2015). The class C GPCRs consist of eight
metabotropic glutamate receptors (mGluRs), two γ aminobutyric acid (GABA) receptors, single
calcium sensing receptor (CASR), and sweet and amino acid taste receptors, pheromone
receptors, and odorant receptors (Pin, 2003). As the L-glutamate is the most prevalent
neurotransmitter in the excitatory synapses in the mammalian CNS, the mGluRs are of particular
interest in its therapeutic utility to treat various neurological and psychiatric disorders.

12

Figure 1.1 Schematics of GPCR signal cascade and downstream effects. Examples of
different sensory inputs are listed in the box. Four discrete G-proteins are depicted in the diagram
above. The following blue arrows indicate the corresponding targets being activated by each Gprotein. The bottom-most box contains a partial list of the physiological effects occurred by these
G-proteins (Schou, 2015).
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Figure 1.2 Diagram of Class C GPCR as a homodimer. Venus flytrap domains are located at
the extracellular ligand binding domains serving as orthosteric binding sites. The proposed
mechanism distinguishes three different state of the homodimer based on ligand availability in
the binding sites (Niswender, 2010).
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1.2. Metabotropic glutamate receptor II (mGluR2)

The mGluRs can be further categorized into three distinct groups (group I, II, III) according
to G-protein coupling, ligand selectivity, and sequence homology (Niswender, 2010). The
mGluR2 belongs to the group II of these sub-classes along with mGluR3. The mGluR2 are
characteristically coupled to Gi/o alpha proteins inhibiting activities of adenylyl cyclase, which in
turn decrease intracellular cAMPs (Figure 1.3). This regulation of the secondary messenger
modulates neurotransmitter synthesis, storage, release, receptor sensitivity, neuronal growth and
differentiation (Duman & Nesler, 1999).

1.2.1. Glutamate hypothesis of schizophrenia

Glutamatergic neurotransmission is required in most of the normal brain functions in that
it is also responsible for many neuropathological disorders such as schizophrenia. There are
numerous reports suggesting that disruptions of neurotransmitter communication contribute to
such clinical conditions (Brichta, 2013; Marecos, 2014). The group II mGluRs are of particular
interest in schizophrenia research due to the glutamate hypothesis, which speculates dysfunction
of glutamatergic neurotransmission to be involved in the etiology of schizophrenia (Javitt, 2012).
With the basis of the hypothesis, mGluR2 and mGluR3 have been investigated for their possible
influences from different parts of post-mortem human brain. One particular study compared the
expression levels between affected and unaffected schizophrenia brain samples. The expression
levels of the group II mGluRs showed lower level of mGluR2 in the prefrontal cortex and
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cerebellum while there was not a significant change in the mGluR3 levels (Gonzalez-Maeso,
2008).

1.2.2. Homo-dimerization of mGluR2

Along with the other groups of mGluRs, mGluR2 takes a functional form as a strict
homodimer. Hence, there may be a mixed population of monomeric and dimeric mGluR2 in the
cells that expresses this protein. Although the comprehensive mechanism for this dimerization is
still unclear, a number of studies previously suggested the involvement of different
transmembrane interactions as a part of possible mechanism (Moreno, 2016; Xue, 2014).
Furthermore, another report showed a cooperativity as a homodimer mechanism via
communication between two ligand binding domains (LBDs). G-protein activation requires
dimerization of full length mGluRs and is partially mediated by an intersubunit disulfide bridge
between the LBDs (Levitz, 2016). However, the latter claim is still subject to questions as there
has not been a thorough investigation on this particular matter, which is a compelling idea for
discussion as it is the only known residue that participates in an extracellular intersubunit
covalent bonding. Thus, this topic alone deserves experimentation of its own.

1.2.3. Conserved cysteine residue at position 121

The intersubunit disulfide bridge between the LBDs is formed by two cysteine residues at
position 121. It is the only known cysteine residue that covalently connects two mGluR2s from
the extracellular domains although there are several other cysteines that are available for
16

disulfide linkage (Niswender, 2010; Rondard, 2006). This residue is conserved throughout all
mGluRs and is known to play its role in stabilizing the mGluR2 homodimer structure in
conjunction with hydrophobic interaction between the LBDs (Levitz, 2016, Figure 1.4).
However, the precise functions of C121 is still controversial due to the lack of thorough
investigation on this topic. This calls upon an inquiry for further study on this specific cysteine
residue to elucidate its effect on dimerization, functionality, and trafficking of mGluR2.

17

Figure 1.3 Gi/o dependent adenylyl cyclase inhibition mechanism. Activated Gi/o protein
inhibits adenylyl cyclase preventing the conversion of ATP into cAMP. Decreased cAMP level
ultimately prevents release of glutamate from the presynaptic terminal of neurons (Li, 2015).
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Figure 1.4 mGluR2 homodimer. Two mGluR2 protomers come together to form a quaternary
structure with multiple contacts at ligand binding domains and transmembrane domains. The
C121 contributes to the stability of the homodimer structure via extracellular disulfide bridge
(Moller, 2017).
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1.3. 5-HT2A-mGluR2 Heteromerization

Heteromerization between different receptors is a unique physiological phenomena that it
can promote or attenuate original signal transduction which can lead to a new signaling pathway
in some cases. (Albizu, 2010; Figure 1.5). Namely, a number of evidences corroborates such
existence of class A GPCR heterodimers, although the topic is still in debate (Franco, 2016;
Moutkine, 2017). The serotonin 5-HT2A, a class A GPCR, and the mGluR2 are known to
heterodimerize, and they have been linked to the pathophysiology of schizophrenia (GonzalezMaeso, 2008; Levitz, 2016; Moreno, 2016; Xue 2015). In the HEK-293 cells that co-express 5HT2A and mGluR2, a synthetic mGluR2 agonist could increase the intracellular calcium level
with the absence of 5-HT2A agonist suggesting that the crosstalk was initiated from the activation
of mGluR2 inducing downstream signal transduction via 5-HT2A-coupled Gq alpha protein,
which activates the phospholipase C that triggers inositol triphosphate (IP3) calcium signaling
pathway (Moreno, 2016).

1.3.1. Potential mGluR2 homodimer interference in the heteromerization

As two mGluR2 protomers are covalently stabilized by C121, it is possible that the
presence of homodimer can potentially interfere with the formation of 5-HT2A-mGluR2
heteromer. While these receptors can theoretically form a multi-complex oligomer between two
homodimers, a few reports suggest a possible combination of heteromer potentially consisting of
5-HT2A and mGluR2 monomers (Baki, 2016; Moreno, 2018). However, it is difficult to propose
a mode of interaction without an explicit structural information of the homodimer or heteromer,
20

or a properly devised mechanism. In order to elucidate this crosstalk mechanism, it calls for the
need for an in-depth investigation on the role of C121 as it may constitute a crucial part of
forming a homodimer.

1.3.2. Heteromer crosstalk in a mouse model

Hallucination is one of the hallmark positive symptoms of schizophrenia (Lysaker, 1999).
In addition, increased expression of 5-HT2A and decreased expression of mGluR2 in the
prefrontal cortex of the human post-mortem sample were reported (Gonzalez-Maeso, 2008).
Thus, many seratonergic hallucinogens such as lysergic acid diethylamide (LSD) and 2,5dimethoxy-4-iodoamphetamine (DOI) are used to emulate psychotic behaviors in mice and rats,
which exhibits peculiar side-to-side head movements, known as head twitch response (HTR),
upon receiving the drugs (Willins, 1997). As the LSD-induced hallucination resembled positive
symptoms of schizophrenia, 5-HT2A activation in the prefrontal cortex led to the development of
psychosis model in rodents. Therefore, 5-HT2A signaling efficiency was coupled to a prediction
of vulnerability to psychiatric illness (Gonzalez-Maeso & Meana, 2006). Furthermore, the
activation of mGluR2 seems to modulate the effect of 5-HT2A-dependent hallucinogens. In that
regard, 5-HT2A-mGluR2 heteromer was explored as a therapeutic target for schizophrenia in a
mouse model by attempting to inhibit the HTR from mGluR2 activation (Benvenga, 2018).
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Figure 1.5 Schematics for different actions of heteromer mechanism. (a) Depiction of
receptor desensitization upon binding corresponding ligand. (b) Heteromerization can affect the
ability of ligand binding. Two receptors can show positive (+) or negative (-) cooperativity,
which can either increase or decrease affinity for ligands. (c) Heteromer can engender a new
signal pathway and produce different physiological responses that were not possible in
monomeric or homodimeric forms (Albizu, 2010).
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Chapter 2. Objectives

The mGluR2 is considered an important piece to a variety of neuropathological disorders in
the range from depression to Alzheimer’s disease (Duman, 2018; Lee, 2009). This receptor has
been in the center of conversation as a key element for the glutamate hypothesis of
schizophrenia. Since the evidence for 5-HT2A-mGluR2 heteromer existence was published, this
heteromer revealed a new scope of understanding the mechanism of this psychotic disorder and
attracted attention as a potential therapeutic target. While the crosstalk between these receptors
were biochemically demonstrated previously (Gonzalez-Maeso, 2008), the mechanism behind
the process has not been clearly elucidated. It is partially due to the class C GPCRs’ ability to
constitutively form a strict dimer. Hence, the study of mGluR2 homodimer is a crucial part to
illustrate comprehensive picture of the crosstalk mechanism. In order to better understand the
process of mGluR2 homodimer formation, C121 holds a great value as this conserved cysteine
residue readily forms extracellular disulfide bridge between two LBDs, which stabilizes overall
homodimer structure. To further investigate the role of C121 in homodimer formation and the
impact of mGluR2 modulation of 5-HT2A in a schizophrenia mouse model, the following four
aims were employed:

1. Evaluate the effect of C121A on subcellular localization of mGluR2 in HEK-293 cells.
2. Investigate the changes in the binding affinity and binding potential of the C121A
mutant.
23

3. Assess the mGluR2 monomer-dimer equilibrium between the WT and C121A mutant.
4. Examine the Gi coupling to assess the functionality of mGluR2
5. Characterize the modulating effect of mGluR2 on 5-HT2A-dependent head twitch
behavior in animal models of psychosis.
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Chapter 3. Materials and Methods
3.1. Construction of mGluR2-C121A plasmid

Previously constructed pcDNA3.1(+)-HA-mGluR2-mCitrine plasmid by Dr. Javier
Gonzalez-Maeso was used as a template to introduce a single point mutation via QuikChange II
Site-Directed Mutagenesis Kit according to the protocol of manufacturer (Agilent). All PCR
assays were performed with PfuUltra High-Fidelity DNA polymerase (Agilent). Cycling
conditions were 16 cycles of 95oC for 30s, 55oC for 1 min, and 68oC for 9 minutes with an initial
denaturation step of 95oC for 30s. Forward (5’GGCTCACGCCACATCGCGCCCGACGGCTCTTAT-3’) and reverse (5'ATAAGAGCCGTCGGGCGCGATGTGGCGTGAGCC-3') mutagenesis primers were ordered
(Agilent). The PCR product was transformed into XL1-Blue Competent Cells according to the
protocol of manufacturer (Stratagene). The selected bacterial colonies were cultured in the LBampicillin medium for 18 hours, and the plasmids were purified using the QIAGEN plasmid
Miniprep and Maxiprep kits. Purified plasmids were digested with NheI and XbaI restriction
enzymes for band analysis. Band weight confirmed plasmid samples were sequence verified as a
final step of quality control (Eurofin).

3.2. HEK-293 transient transfection of mGluR2-C121A plasmid

HEK-293 cells were maintained in the Dulbecco’s modified Eagle’s medium (DMEM;
contains 4.5 g/L glucose) supplemented with 10% (v/v) dialyzed fetal bovine serum (dFBS) and
25

1% (v/v) P/S at 37°C in a 5% CO2 humidified atmosphere. dFBS was used to prevent
contamination by glutamate from using undialyzed FBS. Transfection for immunofluorescence
microscopy and western blot was performed with PEI using 3ug of plasmid materials incubated
for 24 hours. For the rest of application, transfection was performed with PEI using 10ug of
plasmid materials without P/S for 24 hours. Lower amounts of DNA materials were used for the
former assays due to their sensitivity to over-expression of the receptors.

3.3. Generation of stably expressing cell line

HEK-293 cells were transiently transfected as described in 3.2. After 24 hours
incubation, the cells were split into 1:200, 1:400, and 1:600 dilutions and allowed for them to
stabilize in DMEM (contains 4.5 g/L glucose) supplemented with 10% (v/v) dFBS and 1% (v/v)
P/S at 37°C in a 5% CO2 humidified atmosphere. After 24 hours, the medium was replaced with
the DMEM supplemented with hygromycin B (250 ug/ml) for selection. Until adequate number
of foci was grown, the culture was continuously supplied with a new DMEM containing
hygromycin B. Once foci matured, they were screened for fluorescence under the microscope.
The medium was removed and washed with pre-warmed Dulbecco's phosphate-buffered saline
(dPBS). Foci were circumscribed with cloning rings and completely isolated from their
surroundings. The cloning rings were adhered to the plate with 2% agarose gel. Foci were
trypsinized (Thermofisher) and transferred to 96-well plates for morphology screening.
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3.4. Immunofluorescence microscopy

HEK-293 cells were grown on poly-D-lysine-treated glass coverslip (number 0 thickness)
and transiently transfected to express either HA-mGluR2-mCitrine or HA-mGluR2-C121AmCitrine. After 24 hours transfection period, the medium was removed and the cells were fixed
with 2% PFA for 15 minutes followed by three 10 minutes washes with PBS. For
permeabilization, 0.2% Triton-X-100 was treated for 10 minutes at RT followed by three 10
minutes washes with PBS. To reduce the unspecific binding of antibodies, the cells were blocked
with BSA prior to the incubation with antibodies. The cells were incubated with the mouse antiHA tag antibody (Cell Signaling) for 60 minutes in RT followed by three 5 minutes washes with
PBS. For additional block after primary antibody incubation, the cells were washed with BSA
three times for 5 minutes. The cells were incubated in dark with the rabbit anti-mouse antibody
labeled with Alexa Fluor 594 (ThermoFisher) for 60 minutes in RT followed by three 5 minutes
washes with PBS. For nuclei staining, the cells were incubated with Hoechst 33342 dye solution
(ThermoFisher) in dark at RT for 5 minutes followed by three 5 minutes washes with PBS.
Residual PBS is gently washed with distilled water. The coverslip was inverted onto Vectashield
antifade on a microscope slide and sealed with nail polish. Zeiss LSM 710 confocal fluorescent
microscope was used to resolve the prepared slides.
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3.5. Membrane preparation

The cells were harvested by centrifugation (1,000 g, 5 minutes, 4oC) in cold dPBS. dPBS
was aspirated and the cell pallet was frozen at least for an hour. The cells were thawed and
homogenized in an ice-cold Tris buffer (50 mM Tris-HCl, pH 7.4). The homogenate was
centrifuged (1,000 g, 5 minutes, 4°C) to remove nuclei, and the supernatant was collected and
centrifuged (40,000 g, 10 minutes, 4°C). The pellet was washed with 5 ml of ice-cold Tris buffer
and recentrifuged (40,000 g, 5 minutes, 4°C). The resultant pellet was stored at -80°C for future
use.

3.6. Western blot

The amount of protein in the membrane preparation was estimated using Bradford assay.
20 ug of proteins were chemically reduced with 2-mercaptoethanol. The protein sample was
resolved in 10% SDS-PAGE and transferred to nitrocellulose membranes by electrophoresis
overnight. The membranes were blocked with blocking buffer containing milk and BSA for 1
hour at RT, which was then immunoblotted with primary antibody (mouse anti-HA, 1:1000,
Abcam) overnight at 4oC. Subsequently, the membranes were incubated with the horseradish
peroxidase-conjugated secondary antibody (rabbit anti-mouse, 1:5000, Abcam) for 1 hour at RT.
Immunoreactivity was detected from the protein sample by the enhanced chemiluminescence
system (SuperSignal WestPico #34080, Thermofisher) according to the protocol of
manufacturer. The resultant western blot films were analyzed for band intensity by densitometry
using the GelQuantNET software (v. 1.8.2.).
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3.7. [3H]LY341495 saturation binding assay

Various concentrations of [3H]LY341495 (American Radiolabeled Chemicals (ARC).
Cat# ART-1439) from 0 to 15 nM were incubated with 5 ug of membrane proteins per each well
on ice for 60 minutes in a total volume of 200 uL. Subsequently, the concentrations of
[3H]LY341495 used were corrected according to radioactivity measured by TRI-CARB 4910TR
110 V Liquid Scintillation Counter (PerkinElmer). The membrane proteins were re-suspended in
the phosphate buffer (10 mM K2HPO4, 1 mM KH2PO4, 100 mM KBr, pH 7.6). Non-specific
binding was determined for each concentration of radioligand in the presence of 1 mM Lglutamate. For harvesting radioligands, Unifilter-96 cell harvester was used (PerkinElmer). The
96-well plates of the membrane incubation were harvested on the GF/A filter papers soaked in
0.5% PEI. The filter paper was dried at 65oC for 30 minutes. Dried filter paper was soaked with
40 ml Microscint-20 cocktail, which was then counted on Perkin Elmer Microbeta2 2450
microplate counter.

3.8. [35S]GTPγS binding assay

The membrane proteins were prepared as indicated in Section 3.5. The prepared
membranes were re-suspended in the assay buffer (20 mM HEPES, 100mM NaCl, 3mM MgCl2,
1 mM EGTA, pH 7.6) accordingly to accommodate 5 ug per each well. 0.5 nM [35S]GTPγS
(PerkinElmer. Cat# NEG030H250UC) and 50 uM GDP were used along with various
concentrations of LY379268 ranging from 0 to 10 uM to incubate membrane proteins in 30oC for
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2 hours in a total volume of 200 uL per each condition. Non-specific binding was determined
using 10 uM non-radioactive GTPγS. For harvesting radioligands, Unifilter-96 cell harvester was
used (PerkinElmer). The 96-well plates of the membrane incubation were harvested on the GF/A
filter papers soaked in the assay buffer. The filter paper was dried at 65oC for 30 minutes. Dried
filter paper was soaked with 40 ml Microscint-20 cocktail, which was then counted on Perkin
Elmer Microbeta2 2450 microplate counter.

3.9. Automated head twitch behavior test

Small magnets were previously implanted on the skull of adult C57BL/6 mice by Dr.
Mario de la Fuente Revenga. The mice were weighed and calculated for proper drug dosing.
These mice were placed in copper-wire-wrapped plastic chambers to capture their HTRs from
the NI DAQ data acquisition system (National Instruments; Figure 3.1). First, the baseline HTR
of these mice were captured for 15 minutes as a habituation process. Appropriate test drugs were
intraperitoneally administered followed by HTR measurement for a designed time period. After
the drug interval, the head twitch was induced by DOI and captured for a designed time period.
The mice underwent washout period of at least 1 week prior to any experiments. The
experiments were repeated by crossing the group.
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3.10. Data Analysis

In Bradford assay, the total protein contents of the samples were estimated by
interpolating the integrated optical density of different concentrations of BSA proteins. Two
binding assays conducted in this thesis, [3H]LY341495 saturation assay and [35S]GTPγS
functional assay, were analyzed with GraphPad Prism software using a one-site nonlinear
regression model to plot the graph. The vertical axis of [3H]LY341495 saturation binding assay
was reported as femtomole of radioligands bound to mg of total proteins. This allowed the
calculation of equilibrium dissociation constants (Kd) and the maximal number of binding sites
(Bmax), which were used to calculate the binding potential as described in Chapter 4.3. The
vertical axis of [35S]GTPγS functional binding assay was reported as relative fold increases from
the basal activity. Corresponding statistical comparison shown on Figure 4.6.2 was conducted
using unpaired t-test between mGluR2-WT and mGluR2-C121A.
For assessing the automated head twitch behavior data, the GraphPad Prism software was
used to plot the data in bar graphs. Multiple t-tests were used to statistically compare the
difference in two experimental groups (vehicle versus LY341 or LY404 groups). Statistical
significance of experiments involving multiple groups with two experimental conditions was
assessed by two-way ANOVA followed by Sidak’s post hoc test. All data are presented as mean
± standard error of the mean (SEM). All statistical comparisons were made at a p-value of 0.05
unless stated otherwise.
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Figure 3.1 Set up for NI DAQ data acquisition system. Two acquisition systems are
simultaneously being operated. Copper wires (red) are wrapped around the plastic chamber
where the mice were enclosed inside during the behavioral test. The chamber was closed with
mouse cage covers to prevent escape.
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Chapter 4. Results
4.1.

Visualization of receptor expression and its subcellular localization

The expression and subcellular localization of the HA-tagged mGluR2-WT and mGluR2C121A were evaluated under the confocal fluorescence microscope. The HEK-293 cells were
transiently transfected with either mGluR2-WT or mGluR2-C121A, thus the reason for
untransfected population of cells in the image. In the case of non-permeabilized cells, the
antibody seems to bind on the surface of the cells that expresses either receptors (Figure 4.1.1).
When the cells were treated with Triton-X-100, a chemical detergent, to permeabilize the plasma
membrane to allow antibodies to bind receptors that are subcellularly located inside the cell, the
co-localization between mCitrine (green) and anti-GFP (red) was more distinctively visible
(Figure 4.1.2). Also, there was a noticeable number of burst cells that had lost fluorescence from
mCitrine while retaining signals from the antibody appearing in red (not shown). Comparing the
cells with intact structural integrity, the mGluR2-C121A seems to show more accumulation
inside the cells compare to the wild type receptor. In regards to the plasma membrane, a
qualitatively comparable fluorescence around the cells is suggestive of the receptor presence at
the cell surface even with the permeabilization.
Next, the expression profile of the stable cell lines that expresses either mGluR2-WT or
mGluR2-C121A were assessed, thus the spinning disc confocal microscopy was employed for
higher resolution imaging (Figure 4.2). Similar to the results from the immunofluorescence
microscopy, both receptors seem to traffic to the cell surface. In contrast, the subcellular
aggregates of the C121A mutant was not detectable in this live cell imaging.
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Figure 4.1.1 Immunofluorescence microscope images without permeabilization. HEK-293
cells were transiently transfected with either mGluR2-WT or mGluR2-C121A. The nuclei were
stained with Hoechst dye (blue). The proteins were visualized by the conjugated mCitrine
fluorescence protein (green) and the anti-HA antibody labeled with fluorophore (red). The wild
type mGluR2 (top row) is compared with mGluR2 with C121A mutation (bottom row).
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Figure 4.1.2 Immunofluorescence microscope images with permeabilization. HEK-293 cells
were transiently transfected with either mGluR2-WT or mGluR2-C121A. The nuclei were
stained with Hoechst dye (blue). The proteins were visualized by the conjugated mCitrine
fluorescence protein (green) and the anti-HA antibody labeled with fluorophore (red). The wild
type mGluR2 (top row) is compared with mGluR2 with C121A mutation (bottom row).
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Figure 4.1.3 Transfection optimization. (A) 3ug plasmids with PEI (B) 10ug plasmids with
PEI (C) 10ug plasmids with PEI (without P/S) (D) 10ug plasmids with PEI (without P/S) (E) 6ug
plasmid with Lipofectamine 2000 (without P/S) (F) 12ug plasmids with Lipofectamine 2000
(without P/S)
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Figure 4.2 Spinning disc confocal microscopy. Live cell images of the HEK-293 cells stably
expressing either mGluR2-WT or mGluR2-C121A. The apparent difference in fluorescence
intensity is attributed to the focal point, not the expression level of the receptors. (A) mGluR2WT (B) mGluR2-C121A.
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4.2.

mGluR2 monomer-dimer equilibrium assessment by western blot

The western blot was performed on the membrane preparation of HEK-293 cells stably
expressing either mGluR2-WT or mGluR2-C121A (Figure 4.3). The monomeric HA-tagged
mGluR2 with mCitrine fluorescent protein after post-translational modification weighs about 140
kDa. Therefore, theoretical molecular weight of the homodimer would be about 280 kDa. The
alpha-tubulin was detected as a loading control to ensure that equal amount of proteins were
loaded.
As predicted, both monomeric and dimeric forms of the receptor were detected at the
expected size on the wild type. The mutant mGluR2, on the other hand, had a significantly less
dimeric form of the receptor compared to that of the wild type. The 140 kDa band intensities
corresponding to the mGluR2 monomer was comparably similar between the wild type and the
mutant.
For quantification of the bands, the intensity of these four bands (140 and 280 kDa of WT
and C121A) were analyzed with densitometer, and the band intensity was plotted after
normalized to the loading control (Figure 4.4). Similarly with the initial qualitative assessment,
the band intensity for the mutant dimer was lower than that of the wild type while the band
intensities corresponding to the monomer were comparably similar.
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Figure 4.3 Western blot of the membrane preparation. mGluR2-WT (left) and mGluR2C121A (right) show both monomeric and dimeric bands at 140 kDa and 280 kDa, respectively.
There is significantly less dimeric population of the mutant relative to the wild type according to
the estimation by the qualitative assessment on the WB. The monomeric band intensity of the
wild type and mutant is comparable. The alpha-tubulin was detected as a loading control.

39

Figure 4.4 Quantified western blot band intensity by densitometer. Each intensity is
normalized to the density counts of the alpha-tubulin. (A) the band pertinent to a monomeric
mGluR2 receptor. The density counts are comparable. (B) the band pertinent to a dimeric
mGluR2 receptor. The density counts are higher on mGluR2-WT.
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4.3.

Change in binding potential in [3H]LY341495 saturation binding assay

The effect of the C121A mutation on binding characteristics was examined with
radioligand binding assay. The membrane preparation was incubated with the radioactive
mGluR2/3 antagonist, [3H]LY341495, and the result was graphed with respect to the fmol of
radioligand bound to milligram of total proteins (Figure 4.5). For this experiment, the HEK-293
cells stably expressing either mGluR2-WT or mGluR2-C121A were used as a source of
receptors. Multiple clones of each cell line were used as replicates to confer statistical power.
Binding curves produced from these clones were combined to generate Figure 4.5.
The Bmax refers to the total density of the receptors and is largely dependent on the
expression level of the receptor in the cell. The Kd is the radioligand equilibrium dissociation
constant, which is the inverse of the receptor affinity to the ligand. Interestingly, both the Bmax
and Kd values were comparably similar as opposed to the initial hypothesis.

Comprehensively, the BP (binding potential) coins these two different terms together to
estimate a specific binding capacity of the receptor. As a result of the similar Bmax and Kd values
between the wild type and the mutant, the BP was not significantly affected by the C121A
mutation.
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Figure 4.5 Slightly lower binding potential of the mGluR2-C121A. The [3H]LY341495
saturation binding curves are plotted. Due to the similar Bmax and Kd values, the BP of the wild
type and mutant is comparably similar. Calculated BP values for mGluR2-WT and mGluR2C121A are 15497 and 12071, respectively. The experiments were performed in duplicate.
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4.4.

[35S]GTPγS functional assay indicates affected G-protein coupling

In order to assess the functional aspect of the mGluR2 upon C121A mutation, Gi
coupling of the receptor was examined by [35S]GTPγS functional binding assay. The radioactive
GTPγS was incubated with the membrane preparation at different concentration of LY379268, a
mGluR2/3 agonist, to allow the constitutive activation of the receptor. The vertical axis was
reported as fold increases from the basal level of activation maintained without any agonist
(Figure 4.6.1). Multiple clones of HEK-293 cells that either expresses mGluR-WT or mGluR2C121A were used in this experiment to confer higher statistical power.
A combined binding curve from five different clones expressing mGluR2-C121A showed
diminished Gi coupling compared to that of the wild type (Figure 4.6.1). The EC50 is a value of
the concentration of a drug at which half of the maximal response occurs. The EC50 value for
mGluR2-WT is approximately 22 nM. As the mutant binding curve is slightly shifted to the
right, the EC50 value has resultantly increased for mGluR2-C121A, which occurs around 40 nM.
Each point of experiment with varying concentrations of LY379268 was quantitatively compared
between the wild type and the mutant by unpaired t-test (Figure 4.6.2). The most significant
statistical difference was observed at 100 nM concentration where the EC50 occurs.

43

Figure 4.6.1 Decreased Gi coupling of the mGluR2-C121A. The [35S]GTPγS binding curves
are plotted. Diminished activation can be seen from mGluR2-C121A compared to the wild type.
The curve is slightly shifted to the right responsible for the slightly increased EC50 value. The
experiments were performed in triplicate.
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Figure 4.6.2 Quantitative analysis of the [35S]GTPγS binding assay. Each point of LY379268
concentration was compared using unpaired t-test (p < 0.05). Statistical difference was began to
be seen from 10 nM LY379268. The most significant difference between the wild type and the
mutant was observed at 100 nM concentration of LY379268 where their EC50 values occur.
***P < 0.001, ****P < 0.0001. Data are means ± SEM of experiments performed in triplicate.
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4.5.

mGluR2 modulation in 5-HT2A-dependent psychosis mouse model

The effect of functional mGluR2 was evaluated in mice that were evoked DOI-induced
head twitch behavior. In the first experiment, the mGluR2/3 antagonist, LY341495 (3 mg/kg),
was administered in mice before they were injected with DOI (0.5 mg/kg) to induce the HTR.
The analyzed data were plotted to compare the HTR between the saline and LY341 group
(Figure 4.7.1; Figure 4.7.2). The HTR of the saline group was maintained on the average of 20
head twitches in each 15 minutes blocks for 90 minutes. The HTR of the LY341 group was
significantly enhanced after 30 minutes of the drug administration where the most difference can
be seen in the first 45 minutes of DOI injection. Furthermore, the drug itself did not increase the
HTR. The effect of the drug was seen only when 5-HT2A-dependent HTR was induced by DOI.
After 45 minutes since the DOI administration, the HTR started decreasing as the drugs were
being washed out.
The following experiment was performed with the mGluR2/3 agonist, LY404039 (5
mg/kg). The previous experiments (Figure 4.9.1; Figure 4.9.2) indicated relatively short half-life
of the drug, thus the drug incubation time was maintained only for 5 minutes before injecting
mice with DOI (1 mg/kg). The analyzed data were plotted to compare the HTR between the
saline and LY404 group (Figure 4.8.1; Figure 4.8.2). As the DOI used in this experiment was
doubled, the average HTR was higher than that of LY341. For the LY404 group, the HTR was
significantly attenuated in the first 30 minutes. After the active drug period, the head twitch
counts continued to increase until they reached the comparable level as the saline group. Similar
to the LY341 experiment, the LY404 itself did not decrease the head twitch counts.
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Figure 4.7.1 Positive 5-HT2A modulation by mGluR2 deactivation. The initial 15 minutes of
basal measurement served as habituation period. Either vehicle (saline) or drug (LY341495) was
injected into mice after the habituation period. After 30 minutes from the time of injection, DOI
was administered. HTR of animal was recorded throughout the experiment. Statistically
significant multiple t-tests in all DOI groups (p < 0.05).
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Figure 4.7.2 Positive 5-HT2A modulation by mGluR2 deactivation. The initial 15 minutes of
basal measurement served as habituation period. The mice were injected with either saline or
LY341495. Two-way ANOVA analysis shows statistically significant interactions between
saline and LY341 groups (F(8,234) = 3.986; P = 0.0002). p < 0.05, significant difference was
observed between the period of DOI(15m) and DOI(75m) from the ANOVA and Sidak’s post
hoc tests. ** P < 0.01, ***P < 0.001, ****P < 0.0001. Notice statistical significance is lost after
75 minutes of DOI administration (n = 14 per each group).
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Figure 4.8.1 Negative 5-HT2A modulation by mGluR2 activation. The initial 15 minutes of
basal measurement served as habituation period. Either vehicle (saline) or drug (LY404039) was
injected into mice after the habituation period. After 5 minutes from the time of injection, DOI
was administered. HTR of animal was recorded throughout the experiment. Statistically
significant multiple t-tests in first two DOI groups (p < 0.05).
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Figure 4.8.2 Negative 5-HT2A modulation by mGluR2 activation. The initial 15 minutes of
basal measurement served as habituation period. The mice were injected with either saline or
LY404039. Two-way ANOVA analysis shows statistically significant interactions between
saline and LY404 groups (F(7,176) = 7.126; P < 0.0001). p < 0.05, significant difference was
observed between the period of DOI(15m) and DOI(30m) from the ANOVA and Sidak’s post
hoc tests. ** P < 0.01, ****P < 0.0001. Notice statistical significance is lost after 30 minutes of
DOI administration (n = 12 per each group).

50

Figure 4.9.1 LY404039 incubation for 30 minutes. The initial experiment with 30 minutes of
drug incubation. Either vehicle (saline) or drug (LY404039) was injected into mice after the
habituation period. After 30 minutes from the time of injection, DOI was administered. HTR of
animal was recorded throughout the experiment. Notice the decrease in head twitch counts while
the drug is still effective during the first 15 minutes of DOI administration (n = 6 per each
group). Statistically significant multiple t-tests in only the first DOI groups (p < 0.05).
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Figure 4.9.2 LY404039 incubation for 30 minutes. The initial 15 minutes of basal
measurement served as habituation period. The mice were injected with either saline or
LY404039. Two-way ANOVA analysis shows statistically significant interactions between
saline and LY404 groups (F(8,90) = 2.152; P = 0.0387). p < 0.05, significant difference was still
observed at the time period of DOI(15m) from the ANOVA and Sidak’s post hoc tests. Most of
the statistical power is lost compared to the subsequent experiment with 5 minutes drug injection
(Figure 4.8.2). *P < 0.05. Notice statistical significance is immediately lost after 15 minutes of
DOI administration (n = 6 per each group).

52

Chapter 5. General Discussion
In order to elucidate the functional role of C121 in homodimeric mGluR2, a point
mutation was introduced in the human mGluR2 gene to replace cysteine with alanine at the
corresponding location. The mGluR2 carries the HA-tag at N-terminal end with the mCitrine
fluorescent protein conjugated at the C-terminal end of this protein. These two elements were
engineered into its gene primarily for visualization purposes by serving as epitopes for antibody,
which were used on immunofluorescence microscopy and western blot protocols. Furthermore,
the first 54 bps of the gene, which translates the human mGluR2 signal peptide, was replaced
with the rat mGluR5 signal peptide sequence, because the signal peptide cleavage during
translocation into endoplasmic reticulum (ER) also removed the HA-tag in the process.
Therefore, the rat mGluR5 signal peptide sequence was used instead, which would still localize
the mGluR2 into the ER while it does not interfere with the functionality of the receptor (Bhave,
2003).
Next, sequence verified mGluR2 recombinant genes were transiently transfected into the
HEK-293 cells. As the previous experiment (not shown) with 48-hour incubation showed
comparable expression level of 24-hour incubation, all subsequent experiments were carried out
with a 24-hour incubation period. Also, the transfection protocol was optimized prior to the
experiments (Figure 4.1.1). Since the transfection with PEI using 10 ug of plasmids without
antibiotics yielded highest transfection efficiency, such specifics were used throughout the
experiment. On a side note, the PEI was selected over Lipofectamine 2000 due to the economic
advantage and Lipofectamine’s sensitivity to plasmid to Lipofectamine ratio, which attributes to
53

the transfection failure when 12 ug plasmids were used without compensating for the vehicle
reagent (Figure 4.1.1, F).
The effect of C121A mutation on the receptor expression and subcellular localization was
explored by using immunofluorescence microscopy technique. The cells grown on the coverslips
were also treated with a chemical detergent to perforate the cell membrane. The anti-HA tag
antibody was used to detect the receptors trafficked to the cell surface where the antibody was
only accessible as long as the cell did not lose its structural integrity. As it can be seen from the
immunofluorescence images (Figure 4.1), the fluorescence from the antibody was detected on
the non-permeabilized cell surface, which suggests that the mutation did not compromise
receptor’s ability to traffic to the cell membrane. However, the effect of this mutation on
trafficking should not be disregarded as it can partially affect the process. When the cells were
permeabilized with the detergent, the signal from antibody accurately co-localized with mCitrine
fluorescence indicating that there is subcellular population of the intact receptors. For that
matter, the mutation seems to subcellularly accumulate receptors in the cells. One hypothesis is
that the lack of covalent stability lowered the efficiency of dimerization in that it increased the
number of monomeric receptors in the cells, which were unable to traffic to the cell surface.
However, this idea is only reasonable if there is an evidence that dimerization occurs prior to
reaching the cell surface. Therefore, the next step would be to produce the receptors that are
incapable of dimerizing to see if monomers traffic to the plasma membrane of the cell. If these
monomers fail to exist at the surface level, it will further support the hypothesis that C121A
affects the homodimerization of mGluR2.
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To bolster the qualitative assessment by immunofluorescence microscopy, the western
blot technique was used to quantitatively analyze mGluR2 monomer-dimer equilibrium (Figure
4.4). Here, previously generated stable cell lines that constitutively expresses either mGluR2-WT
or mGluR2-C121A were harvested for the membrane preparation, which was chemically reduced
before running in the SDS-PAGE. As a side note, the membrane samples were not heat treated
due to the formation of aggregate falsely contributing to increased dimer population. Even after
these harsh treatments, it is surprising to see the presence of significant amount of dimer in the
western blot. It may be due to several other cysteine residues from CRD and LBD that could
potentially contribute to the stability of dimers (Muto, 2007; Niswender, 2010). Regardless, a
distinctive difference in the monomer-dimer equilibrium between these two receptors was visible
(Figure 4.3). The 140 kDa band is approximately the molecular weight of the post-translationally
modified mGluR2-mCitrine. From the quantitative analysis by densitometry, the monomeric
band intensity of both the wild type and the C121A mutant was comparably similar indicating
that expression level of mGluR2 was not affected by possible alteration in trafficking. On the
contrary, the 280 kDa band, that is pertinent to the dimeric population of mGluR2, was affected
by the mutation. As expected, the formation of the dimer was significantly reduced by the
C121A mutation as it was seen from the western blot image. This finding can serve as an
additional evidence that C121A is involved in the dimerization process and structural stability of
homodimer.
Interestingly, there were two bands corresponding to the MW of mCitrine (not shown).
This can be a possible indication that there is a population of the receptor without the mCitrine,
in which case explains the smearing of the band as different combinations of heteromer are
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possible. It is also relevant to note that the intensities of the loading control were comparable.
This further validates the result produced in the western blot.
Subsequently, the effect of C121A mutation on ligand binding property was assessed by
radioligand saturation binding assay with the [3H]LY341495. This substrate is a specific
orthosteric antagonist for group II mGluRs, which is known to increase the effect of 5-HT2Adependent hallucinogenic drugs in a mouse model (Gewirtz, 2000). The ability of binding
mGluR2 orthosteric site and its high affinity to the receptor make [3H]LY341495 a great
candidate for receptor quantification and characterization of binding capacity. As for the receptor
source, the cell lines that stably express either mGluR2-WT or mGluR2-C121A were generated
as previous results from the transiently transfected cells were inconsistent due to the varying
transfection efficiency for each experiment (not shown). Several binding curves generated from
different cell lines were combined to produce two averaged binding curves for comparison.
Surprisingly, binding properties and pharmacokinetics of the receptor was not affected by
C121A mutation. Furthermore, the Bmax and Kd values are comparably similar although
calculated BP values indicates slightly higher binding potentials of wild type receptor. This
suggests that the mutation changed binding affinity to a certain degree, however, it is arguable if
this effect is functionally significant. In spite of these changes, the binding profile does not seem
to be affected for the most part.
In order to investigate the functional consequences of C121A mutation, [35S]GTPγS
binding assay was conducted to assess the heterotrimeric G-protein coupling of mGluR2. A
specific ratio of radioactive GTPγS and GDP was incubated with the membrane preparation to
allow the constitutive activation of the receptor. To activate the receptor, a specific orthosteric
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agonist for group II mGluRs known as LY379268 was used to generate dose-response binding
curves.
While the mutation did not have much impact on pharmacokinetics of mGluR2 as it was
demonstrated from [3H]LY341495 saturation binding assay, it is interesting to see that Gi
coupling has significantly diminished in mGluR2-C121A. It is possibly due to the need for
dimerization in taking activatable conformation. This suggests that binding characteristics of
mGluR2 was not sufficiently influenced by the mutation whereas the dimerization property was
negatively altered to ultimately reduce G-protein coupling affecting the function of the receptor.
Lastly, the mGluR2 modulation of the 5-HT2A-dependent hallucination was revisited in
the context of the head twitch response. This experiment was done as a partial evidence for the
overall scheme of the crosstalk between 5-HT2A and mGluR2, which will help elucidate the
heteromerization mechanism. To achieve that, C57BL/6 mice are injected with either LY341495
or LY404039 that are mGluR2/3 antagonist and agonist, respectively. These pre-treatments were
followed by DOI administration to induce the HTR.
As expected, the LY341495 visibly increased HTR and its effects lasted up to 75 minutes
from the DOI injection until the statistical significance of HTR difference was lost. It is
important to note that the antagonist alone did not alter the head twitch counts. It increased the
counts only in conjunction with the DOI injection despite the low dosage of DOI. These results
demonstrate the ability of LY341495 to potentiate the actions of 5-HT2A by inactivating
mGluR2. Subsequent cross-group experiments resulted in very similar outcomes, which were
then combined with the initial experimental data to produce the reported graphic plot (Figure
4.7.1).
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Followed by the antagonist experiments, the effect of mGluR2 activation on 5-HT2Adependent HTR was investigated using LY404039. Here, the mGluR2 agonist noticeably and
immediately decreased head twitch counts for 30 minutes, which the effect of the drug seems to
have expired after that time point. Similar to the antagonist experiments, the drug was not
responsive to the basal level head twitch counts, and it rather directly modulated the behavioral
effect of 5-HT2A (Figure 4.8.1). In this experiment, the incubation time for LY404039 was
limited to only 5 minutes as the previous experiments with longer incubation period resulted in
less statistical power due to a short half-life of the drug (Figure 4.9.1).
With the 5-HT2A-dependent behavior modulation by either mGluR2 agonist or
antagonist, it was successfully shown here that mGluR2 affects the effect of 5-HT2A. Also, these
drugs specifically targeted the actions of 5-HT2A without changing the basal HTR. In other
words, the antagonist potentiated the 5-HT2A and the agonist interfered with the signaling by 5HT2A. While these animal studies have shown the interaction between 5-HT2A and mGluR2,
these experiments alone do not provide a sufficient evidence for either heteromerization or 5HT2A-mGluR2 crosstalk as they could work independently. However, other studies have already
reported biochemical and electrophysiological corroborations for the existence of 5-HT2AmGluR2 heteromer, thus these behavioral data support the claims for this relatively novel idea
(Albizu, 2010; Gonzalez-Maeso, 2008; Levitz, 2016; Xue, 2015).
Throughout the thesis, continuous efforts to elucidate the role of C121A mutation on
mGluR2 were expressed from the perspective of biochemistry and molecular biology. The
absence of this conserved cysteine residue affected dimerization property leading to more
subcellularly populated monomeric mGluR2 as it was shown by immunofluorescence
58

microscopy while disturbed dimer formation was observed from the western blot. From the
[3H]LY341495 saturation binding assay, the mutation did not seemed to affect binding
characteristics of mGluR2 as both Bmax and Kd values were comparably similar. On the other
hand, Gi coupling was diminished on mGluR2-C121A as it was shown in the [35S]GTPγS
binding assay suggesting a potential adverse impact the mutation has on proper functioning of
mGluR2. Finally, 5-HT2A-dependent increase or decrease in HTR by mGluR2 modulation in a
mouse model further supported the existence of 5-HT2A-mGluR2 crosstalk. As a future direction,
it would be interesting to perform follow-up studies on heteromerization of 5-HT2A with this
particular mutant receptor to compare the receptors interaction and crosstalk efficiency.
Collectively, the C121 plays a notable part in the formation and maintenance of mGluR2
homodimer, and therefore calls for further investigation on subcellular localization, dimerization,
binding affinity, and functionality of mGluR2-C121A as it could shed light on the specifics of
the mGluR2 signal mechanism which may involve 5-HT2A and perhaps other receptors as well.
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